SYNTHESIS AND IN-VITRO ACTIVITY OF 17-BETA-((N-ALKYL/ARYLFORMAMIDO)-4-METHYL-4-AZA-3-OXO-5-ALPHA-ANDROSTAN-3-ONES AND 17-BETA-[(N-ALKYL/ARYL)ALKYL/ARYLAMIDO]-4-METHYL-4-AZA-3-OXO-5-ALPHA-ANDROSTAN-3-ONES AS INHIBITORS OF HUMAN 5-ALPHA-REDUCTASES AND ANTAGONISTS OF THE ANDROGEN RECEPTOR

被引：26

作者：

LI, X ^{[1
]}

SINGH, SM ^{[1
]}

LABRIE, F ^{[1
]}

机构：

[1] CHU LAVAL, RES CTR, DIV MED CHEM, MOLEC ENDOCRINOL LAB, QUEBEC CITY, PQ G1V 4G2, CANADA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1995年 / 38卷 / 07期

关键词：

D O I：

10.1021/jm00007a013

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A number of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-3-oxo-4-aza- 5 alpha-steroids were prepared from 17 beta-hydroxy-4-azasteroids and evaluated as inhibitors of human 5 alpha-reductase and antagonists of the androgen receptor. Jones' oxidation of 17 beta-hydroxy compounds gave the 17-keto-4-azasteroids, which were treated with amines and NaBH(OAc)(3)/NaBH3CN to give 17 beta-(N-alkyl/arylamino)-4-azasteroids 10-27. Alternatively, the above-indicated compounds were prepared from amines and 17-keto-4-azasteroids to form imines, which were then reduced with NaBH4. Formylation of amines 10-27 gave 17 beta-(N-alkylformamides) 28-41; however, acylation afforded 17 beta-[(N-alkyl/aryl)alkyl/arylamides] 42-53. In comparison to N,N-diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide (4-MA; IC50 = 4.15 nM), 17 beta-(N-alkylformamido)-4-azasteroids were potent inhibitors of human type I 5 alpha-reductase, IC50 values of compounds 29, 30, 36, and 37 being measured as 3.05, 0.91, 2.19, and 2.35 nM, respectively. The structure-activity relationships suggest that the type I enzyme has preference for N-substituted straight alkyl side chains of four to five carbon atoms. On the other hand, formamides 32 (N-heptyl) and 33 (N-octyl), in addition to inhibiting the type I enzyme (IC(50)s = 9.57 and 16.9 nM, respectively), showed also strong inhibitory activity (IC50S = 14.0 and 18.4 nM, respectively) for human type II 5 alpha-reductase, in comparison to N-(1',1'dimethylethyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide (MK-906; IC50 = 4.53 nM) Other compounds in this series showed moderate activities (IC50 > 100 nM) on the type II enzyme. 17 beta-[(N-Alkyl/aryl)alkyl/arylamides] 45, 46, 48, and 51 exhibited highly potent inhibitory activity for human type I 5 alpha-reductase with IC(50)s of 1.77, 2.42, 2.93, and 5.44 nM, respectively, while moderate to no effect was observed on the type II enzyme (100 < IC50S < 1000 nM), except for compound 48 (IC50 = 3.75 nM). In another substitution pattern, N-aryl/alkylamides were studied; an electron-donating group increased the potency of compound 51, whereas an electron-withdrawing group decreased the potency of compounds 52 and 53 compared to parent compound 50. In addition to their 5 alpha-reductase activities, 17 beta-(N-alkylformamides) were also studied for their inhibitory activities on dihydrotestosterone (DHT)-stimulated proliferation of androgen-sensitive Shionogi mouse mammary carcinoma cells (clone SEM-107). The inhibition of DHT action on the proliferation of the androgen-sensitive cancer cells by formamido compounds showed moderate to good activity, IC50 values ranging from 45 to 100 nM as compared to hydroxyflutamide (IC50 = 52.5 nM).

引用

页码：1158 / 1173

页数：16

共 71 条

[61]

Baker J.W., Bachman G.L., Schemacher I., Roman D.P., Tharp A.L., Synthesis and Bacteriostatic Activity of Some Nitrotrifluorom- ethylanilides, J. Med. Chem., 10, pp. 93-95, (1967)

[62]

Barton D.H.R., Lester D.J., Ley S.V., Dehydrogenation of Steroidal Ketones Using Benzeneseleninic Anhydride, J. Chem. Soc., Chem. Commun., pp. 130-131, (1978)

[63]

Back T.G., Oxidation of Azasteroid Lactams Using Benzeneseleninic Anhydride, J. Org. Chem., 46, pp. 1442-1446, (1981)

[64]

Barton D.H.R., Hui R.A.H.F., Ley S.V., Williams D.J., Dehydrogenation of Lactones Using Benzeneseleninic Anhydride. X-Ray Crystal Structure of 3β- Acetoxy-14a-hydroxy-17a-oxa-D-homo-5a-an- drost-15-en-17-one, J. Chem. Soc., Perkin Trans. 1, pp. 1919-1922, (1982)

[65]

Bhattacharya A., DiMichele L.M., Dolling U.-H., Douglas A.W., Grabowski E.J.J., Silylation-Mediated Oxidation of 4-Aza- 3-ketosteroids with DDQ Proceeds via DDQ-Substrate Adducts, J. Am. Chem. Soc., 110, pp. 3318-3319, (1988)

[66]

Delos S., Iehle C., Martin P.-M., Raynaud J.-P., Inhibition of the Activity of‘Basic’ 5a-Reductase (Type 1) Detected in DU 145 Cells and Expressed in Insect Cells, J. Steroid Biochem. Mol. Biol., 48, pp. 347-352, (1994)

[67]

Labrie F., Veilleux R., Fournier A., Low Androgen Levels Induce the Development of Andorgen-Hypersensitive Cell Clones in Shionogi Mouse Mammary Carcinoma Cells in Culture, J. Natl. Cancer Inst., 80, pp. 1138-1147, (1988)

[68]

Labrie F., Veilleux R., Fournier A., Glucocorticoids Stimulate the Growth of Mosue Mammary Carcinoma Shionogi Cells in Culture, Mol. Cell. Endocrinol., 58, pp. 207-211, (1988)

[69]

Simard J., Dauvois S., Haagensen D.E., Levesque C., Merand Y., Labrie F., Regulation of Progesterone-Binding Breast Cyst Protein (GCDFP-24) Secretion by Estrogens and Androgens in Human Breast Cancer Cells: A New Marker of Steroid Action in Breast Cancer, Endocrinology, 126, pp. 3223-3231, (1990)

[70]

Fiszer-Szafarz B., Szafarz D., Guevara de Murillo A., A General, Fast and Sensitive Micromethod for DNA Determination: Application to Rat and Mouse Liver, Rat Hepatoma, Human Leukocytes, Chicken Fibroblasts and Yeasts Cells, Anal. Biochem., 110, pp. 165-170, (1981)

← 1 2 3 4 5 6 7 8 →